Global PPE Leader ASAP Innovations featured its X-TRA Thick Black glove at the A + A Exhibition in Dusseldorf
ASAP Innovations, a leading global PPE manufacturer, launched its X-TRA Thick Black glove at the A + A Exhibition in Dusseldorf in October; the glove has been approved for use throughout the EU and in the UK and offers the highest protection against exposure to many commonly – used chemotherapy drugs.
ASAP saw a constant stream of visitors to its Stand across the four days of the Exhibition, which attracted over 25,000 visitors in total.
The X-TRA Thick Black glove has been tested in accordance with ISO 16604:2004 (resistance to penetration by blood – borne pathogens) and has passed to meet the requirements of EN ISO 374-5:2016.
The gloves have been approved for use with a wide range of commonly used chemotherapy drugs, including Cisplatin and Cyclophosphamide (Cytoxan). In addition, they have full – hand texture for enhanced grip, and are powder – free.
All ASAP Innovation’s gloves are available from the company’s European Distribution Partners.
ASAP Innovations was founded in 2018 and is part of ASAP International, a group that started in Malaysia in 1988; the company now has a presence in over 80 countries worldwide, with an extensive range of products used in multiple sectors, including aerospace, automotive, cleanroom, healthcare, food and drink, hospitality, industrial and more.
A + A took place at the Messe Dusseldorf from 26th – 29th October; it is the world’s biggest exhibition dedicated to Health and Safety.
Sean Keller, Managing Director at ASAP Innovations, commented; “It was really fantastic to see so many visitors to our Stand; meeting people face – to – face is vital, and A + A was the perfect platform for launching the newly approved Chemotherapy glove.”
For further information about ASAP Innovations please visit: www.whyasap.ie
